Connection
Maura Gasparetto to Prognosis
This is a "connection" page, showing publications Maura Gasparetto has written about Prognosis.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.196 |
|
|
|
-
Gasparetto M, Pei S, Minhajuddin M, Stevens B, Smith CA, Seligman P. Low ferroportin expression in AML is correlated with good risk cytogenetics, improved outcomes and increased sensitivity to chemotherapy. Leuk Res. 2019 05; 80:1-10.
Score: 0.095
-
Gasparetto M, Smith CA. ALDHs in normal and malignant hematopoietic cells: Potential new avenues for treatment of AML and other blood cancers. Chem Biol Interact. 2017 Oct 01; 276:46-51.
Score: 0.084
-
Smith C, Gasparetto M, Humphries K, Pollyea DA, Vasiliou V, Jordan CT. Aldehyde dehydrogenases in acute myeloid leukemia. Ann N Y Acad Sci. 2014 Mar; 1310:58-68.
Score: 0.017